TRUST ATLAS WORKSHEET
Labeling
Canada medical device licence · Step 2 · Collect class-specific and quality evidence- Who prepares it
- Quality + clinical and technical leads
- When to prepare it
- Before submission
Worked example
This example uses fictional details. Use the same fields with evidence from your work.
- Label location
- Device instructions for use
- Claim or control
- Explain when a low-charge warning appears and what action the user should take.
- Supporting evidence
- Approved intended use, risk control R-014 and usability review
- Version and market
- IFU v3, applicable market and language versions listed
- Approval
- Regulatory and quality approval before release
Gather first
- Approved intended use and indications
- Risk controls, warnings and test evidence
- Labeling rules, markets and device configuration
How to prepare it
- List the required label locations and formats for the product, packaging, instructions and software. Pull claims and warnings from the approved regulatory and risk files.
- Check language, symbol, version and identification requirements in each market. Route clinical, usability and regulatory review and reconcile changes to the design.
- Proof the production art or software screens, approve the exact version and retain a copy with the submission and release records.
Review
The production artifact agrees with the intended use and evidence. Warnings and symbols are consistent across channels.
Handoff
Give the approved labeling files and control history to manufacturing, release and regulatory teams.